期刊论文详细信息
Addiction Science & Clinical Practice
Just call it “treatment”
Peter D Friedmann2  Robert P Schwartz1 
[1] Friends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD, 21201, USA
[2] Warren Alpert Medical School, Brown University, Providence, RI; Providence Veterans Affairs Medical Center, Providence, RI; and the Department of Medicine, Rhode Island Hospital, 593 Eddy Street, Providence, RI, 02903, USA
关键词: Substance abuse treatment.;    Substance abuse counseling;    Opioid dependence;    Methadone;    Behavioral counseling;    Buprenorphine;   
Others  :  789370
DOI  :  10.1186/1940-0640-7-10
 received in 2012-04-17, accepted in 2012-06-09,  发布年份 2012
PDF
【 摘 要 】

Although many in the addiction treatment field use the term “medication-assisted treatment” to describe a combination of pharmacotherapy and counseling to address substance dependence, research has demonstrated that opioid agonist treatment alone is effective in patients with opioid dependence, regardless of whether they receive counseling. The time has come to call pharmacotherapy for such patients just “treatment”. An explicit acknowledgment that medication is an essential first-line component in the successful management of opioid dependence.

【 授权许可】

   
2012 Friedmann and Schwartz; licensee BioMed Central Ltd

【 预 览 】
附件列表
Files Size Format View
20140704174742282.pdf 135KB PDF download
【 参考文献 】
  • [1]Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickenson W, et al.: Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry 2011, 68:1238-1246.
  • [2]Strang J, McCambridge J, Best D, Beswick T, Bearn J, Rees S, Gossop M: Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ 2003, 326:959-960.
  • [3]McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP: The effects of psychosocial services in substance abuse treatment. JAMA 1993, 269:1953-1959.
  • [4]Mattick RP, Breen C, Kimber J, Davoli M: Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009, 3:CD002209.
  • [5]Yancovitz SR, Des Jarlais DC, Peyser NP, Drew E, Friedmann P, Trigg HL, Robinson JW: A randomized trial of an interim methadone maintenance clinic. Am J Public Health 1991, 81:1185-1191.
  • [6]Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CB, Rouse CO, Callaman JM, O'Grady KE, Battjes RJ: A randomized controlled trial of interim methadone maintenance. Arch Gen Psychiatry 2006, 63:102-109.
  • [7]Gruber VA, Delucchi KL, Kielstein A, Batki SL: A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug Alcohol Depend 2008, 94:199-206.
  • [8]Byrne A, Wodack A: Census of patients receiving methadone treatment in a general practice. Addiction Res Theory 1996, 13:341-349.
  • [9]Gossop M, Stewart D, Marsden J, Browne N: Methadone treatment for opiate dependent patients in general practice and specialist clinic settings: outcomes at 2-year follow-up. J Subst Abuse Treat 2003, 24:313-321.
  • [10]Keen J, Oliver P, Rowse G, Mathers N: Does methadone maintenance treatment based on the new national guidelines work in a primary care setting? Brit J Gen Pract 2003, 53:461-467.
  • [11]Gossop M, Marsden J, Stewart D, Lehman P, Strang J: Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: results from the national Treatment Outcome Research Study. Brit J Gen Pract 1999, 49:31-34.
  • [12]Bellis Lewis D: General practice or drug clinic for methadone maintenance? A controlled comparison of treatment outcomes. Int J Drug Policy 2001, 12:81-89.
  • [13]Fiellin DA, Pantalon MV, Chawarski MC, Moore BA, Sullivan LE, O’Connor PG, Schottenfeld RS: Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med 2006, 355:365-374.
  • [14]Mattick RP, Kimber J, Breen C, Davoli M: Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2008, 2:CD002207.
  • [15]Newman RG, Whitehill WB: Double-blind comparison of methadone and placebo maintenance treatment of narcotic addicts in Hong Kong. Lancet 1979, 314:485-488.
  • [16]Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, Banys P, Hall SM: Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA 2000, 283:1303-1310.
  • [17]McLellan AT, Lewis DC, O'Brien CP, Kleber HD: Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000, 284:1689-1695.
  • [18]Schwartz RP, Kelly SM, O'Grady KE, Gandhi D, Jaffe JH: Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings. Addiction 2012, 107:943-952.
  • [19]World Health Organization: Guidelines for the Psychosocially-Assisted Pharmacological Treatment of Opioid Dependence.  , Geneva, Switzerland; 2009.
  • [20]Friedmann PD: Buprenorphine-naloxone works for prescription opioid dependence as long as it is maintained.  ,  ; . http://www.bu.edu/aodhealth/issues/issue_nov11/friedmann_weiss.html webcite
  文献评价指标  
  下载次数:12次 浏览次数:22次